5th Precision CRISPR Genome Editing Congress

5th Precision CRISPR Genome Editing Congress is organized by Hanson Wade and will be held from May 21 - 23, 2019 at The Westin Boston Waterfront, Boston, Massachusetts, United States of America.

Description:
Designed with CRISPR experts from AstraZeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academics worldwide, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery, safety, precision, and efficiency to further optimize the relevant areas of drug discovery, functional screening & CRISPR-based cell & gene therapy.

• Learn about how CRISPR is working in a clinical setting and unique approaches to gene therapy
• Discover advances in disease modeling and strategies improving validation of human biology
• Understand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox
• Explore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases
• Discover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline
• Participate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR

Engineering the Next Generation of Drug Discovery, Cell & Gene Therapy Applications Designed with CRISPR experts from the likes of CRISPR Therapeutics, Astrazeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academic key opinion leaders, this year’s meeting encapsulates the critical scientific challenges and opportunities of CRISPR applications. Tackling delivery, safety, precision and efficiency best practice, further optimize your drug discovery, functional screening and translation of CRISPR-based cell and gene therapy into the clinic. With the first wave of CRISPR based therapeutic clinical trials firmly underway, the 5th Precision CRISPR Genome Editing Congress is perfectly timed to demonstrate the growing applications of CRISPR and unique approaches to gene therapy.

Speakers: TJ Cradick, CRISPR Therapeutics, Jesper Gromada, Exonics Therapeutics, Beeke Wienert, Gladstone Institutes, San Francisc, George M. Church, PhD., Harvard Medical School, Niren Murthy, UC Berkeley, PJ Brooks, NIH Common Fund Program on Somatic Cell Genome Editing, Neville Sanjana, New York Genome Center and Departments of Biology and Neuroscience, Namjin Chung, AbbVie, Leire Escudero-Ibarz, GSK, Ben Kleinstiver, Harvard Medical School, Jonathan Gootenberg, MIT, Omar Abudayyeh, MIT, David Alvarado, Merck, Guru Channabasavaiah, University of Nebraska Medical Center, Stuart Chambers, Amgen, Ultan McDermott, AstraZeneca, Honorary Faculty, Garrett Rettig, IDT, Eric Paul Bennett, University of Copenhagen, Abraham Scaria, Casebia Therapeutics, Megan van Overbeek, Caribou Biosciences, Inc., Dan Tierno, Bayer, Bio-Rad Representative, Horizon Representative, Cellecta Representative

Time: 8:00 am - 5:00 pm